gvtcx

Ribosome profiling of suspension-adapted HEK293 cells producing adeno-associated viruses

CELL AND GENE THERAPY CATAPULT Published 13 Sept 2022 Contracts Finder

key details

Value£180,000
Statuscomplete
Category (CPV) 73111000 +1 more
RegionLondon
Deadline5 Aug 2022
Procedureopen
OCIDocds-h6vhtk-034db7

Award

SupplierValueDateStatus
EIRNA Bio Ltd. · · active

description

Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls. A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1". The samples will then be processed by the awarded Bidder. In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 35 samples will be obtained for either "Run 2" and "Run 3".

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
4 Jul 2022 Contract notice (F02) Earlier regulations 018191-2022
4 Jul 2022 Tender (tender) · 1230e91b-23b1-46c2-aa5b-908872be2217-551802
13 Sept 2022 Contract award notice (F03) Earlier regulations 025600-2022

more from CELL AND GENE THERAPY CATAPULT

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.